Pathway
|
T-Cell Dependent B-Cell Activation
|
|
Immunoglobulin Class-Switch Recombination Activation
|
|
T-Cell Maturation (Hypothesis)
|
|
CD8+ T-Cell Activation
|
|
Th2-Cell Differentiation
|
|
T-Cell Receptor Signaling
|
|
Lipoxins and Resolvins in Inflammation Resolution
|
|
Keep out Signal: LTF Inhibits Neutrophil Recruitment and Inflammation
|
|
Histamine Effects in Inflammation
|
|
Basophil Activation
|
|
Eosinophil Activation
|
|
Mast-Cell Activation without Degranulation through CYSLTR1/CYSLTR2 Signaling
|
|
Mast-Cells De Novo Synthesized Mediators via IgE Independent Signaling
|
|
anti-Inflammatory Function of Macrophage M2 Lineage
|
|
Neutrophil Recruitment and Priming
|
|
Nociception Expression Targets Signaling
|
|
CNR1/2 -> IL1B/2/4/6/10 Production
|
|
Hematopoietic Cell Lineage: B-cell (mouse)
|
|
Proteins Involved in Atherosclerosis
|
|
Proteins Involved in Myocarditis
|
|
Atopic Dermatitis Onset
|
|
Mast-Cells Activation in Atopic Dermatitis
|
|
Genes with Mutations Associated with Atopic Dermatitis
|
|
Acute Phase in Atopic Dermatitis
|
|
Proteins Involved in Atopic Dermatitis
|
|
Atopic Dermatitis
|
|
Proteins Involved in Psoriasis
|
|
Genes with Mutations Associated with Psoriasis
|
|
T-Cells Differentiation Block in Psoriasis
|
|
Proteins with Altered Expression in Psoriasis
|
|
Proteins Involved in Systemic Lupus Erythematosus
|
|
Th1-Cell Function in Systemic Lupus Erythematosus
|
|
Th2-Cell Function in Systemic Lupus Erythematosus
|
|
Genes with Mutations Associated with Vitiligo
|
|
Vitiligo
|
|
T-Cell Cytotoxic Response against Melanocytes in Vitiligo
|
|
Humoral Immunity in Vitiligo
|
|
Natural Killer T-Cell Roles in Diabetes Mellitus Type 1
|
|
Proteins Involved in Diabetes Mellitus Type 1
|
|
Proteins Involved in Diabetic Neuropathy
|
|
Immune Sustem Activation in Hashimoto's Thyroiditis
|
|
Hashimoto's Thyroiditis
|
|
Proteins Involved in Graves Disease
|
|
Graves Ophthalmopathy
|
|
Immune System Activation in Hyperthyroidism
|
|
Proteins Involved in Myasthenia Gravis
|
|
Proteins Involved in Obesity
|
|
Proteins Involved in Celiac Disease
|
|
CD4+T-Cell Response in Celiac Disease
|
|
Proteins with Altered Expression in Celiac Disease
|
|
Celiac Disease
|
|
B-Cell Activation in Crohn's Disease
|
|
Macrophage Dysfunction
|
|
Proteins Involved in Inflammatory Bowel Diseases
|
|
Proteins Involved in Helicobacter Infections
|
|
Leukocyte Migration toward the Endothelial Cell in Ulcerative Colitis
|
|
Proteins Involved in Ulcerative Colitis
|
|
Th2-Cell Function in Ulcerative Colitis
|
|
Proteins Involved in Diffuse Large-B-Cell Lymphoma
|
|
Follicular Lymphoma
|
|
Osteoclast Activation in Multiple Myeloma
|
|
Proteins Involved in Multiple Myeloma
|
|
Proteins Involved in Hepatocellular Carcinoma
|
|
ADAM33 Role in Asthma
|
|
Eosinophil Survival in Asthma
|
|
IgE Induces Airway Smooth Muscle Cell Proliferation
|
|
Goblet-Cell Exocytosis in Asthma
|
|
Goblet-Cell Related Mucus Secretion in Asthma
|
|
Club-Cell Role in Asthma
|
|
Basophil Activation in Asthma
|
|
Antigen-Presenting Cell Role in Asthma
|
|
B-Cell Mediated IgE Production in Asthma
|
|
Th2-Cell Response in Asthma
|
|
Mucin Production in Goblet Airway Epithelial Cells
|
|
Proteins Involved in Osteoarthritis
|
|
PTPN22 Role in Rheumatoid Arthritis
|
|
Proteins Involved in Rheumatoid Arthritis
|
|
FAS Mediated Apoptosis in Systemic Scleroderma
|
|
B-Cells Function in Systemic Scleroderma
|
|
Th2-Cells Function in Systemic Scleroderma
|
|
Proteins Involved in Systemic Scleroderma
|
|
Proteins with Altered Expression in Systemic Scleroderma
|
|
Proteins Involved in HIV Type 1 Infection
|
|
CD4+ T-Cell Function Decline in HIV
|
|
Proteins Involved in Periodontitis
|
|
Proteins Involved in Glioblastoma
|
|
Proteins Involved in Astrocytoma
|
|
Proteins Involved in Glioma
|
|
Proteins Involved in Neuroblastoma
|
|
MBP/MOG/PLP in Immune System Activation
|
|
Proteins Involved in Multiple Sclerosis
|
|
Proteins Involved in Endometriosis
|
|
Proteins Involved in Spontaneous Abortion
|
|
Genes with Mutations Associated with Asthma
|
|
Proteins Involved in Chronic Obstructive Pulmonary Disease
|
|
Mucin Hyperproduction in Goblet and Mucous Cells
|
|
Proteins Involved in Chronic Bronchitis
|
|
Proteins Involved in Polycystic Kidney Disease
|
|
Noradrenaline/Gs Expression Targets
|
|
Noreadrenaline/Gq Expression Targets
|
|
CD19 Expression Targets
|
|
CD81 -> AP-1 Expression Targets
|
|
CD8 -> AP-1 Expression Targets
|
|
CD72 -> CREB/CREBBP Expression Targets
|
|
CD72 -> STAT Expression Target
|
|
CD8 -> ATF/CREB/CREBBP Expression Targets
|
|
CD80 -> AP-1 Expression Targets
|
|
CD80 -> STAT Expression Targets
|
|
CD81 Expression Targets
|
|
CD80 -> NF-kB Expression Targets
|
|
CD86 -> STAT Expression Targets
|
|
CD86-> NFATC Expression Targets
|
|
CD86 -> NF-kB Expression Targets
|
|
CSF2 -> NF-kB Expression Targets
|
|
CSF2 -> STAT Expression Targets
|
|
Tumor Infiltrating Macrophages in Cancer Progression and Immune Escape
|
|
Myeloid Derived Suppressor Cells in Cancer Immune Escape
|
|
Proteins with Altered Expression in Cancer Immune Escape
|
|
Insulin -> STAT Expression Targets
|
|
Insulin -> CEBPA/CTNNB/FOXA/FOXO Expression Targets
|
|
Insulin -> MEF/MYOD Expression Targets
|
|
Insulin -> ELK/SRF/HIF1A/MYC/SREBF Expression Targets
|
|
IFNA1/IFNR Expression Targets
|
|
IFNG/IFNR Expression Targets
|
|
IL4R -> STAT Signaling
|
|
IL4R -> ELK/SRF/HMGY Signaling
|
|
IL7 Expression Targets
|
|
IL15 Expression Targets
|
|
IL12B Expression Targets
|
|
IL3 Expression Targets
|
|
IL4 Expression Targets
|
|
IL2 Expression Targets
|
|
PAF/Gq -> AP-1/ATF1/CREB/ERK/SRF Expression Targets
|
|
Morphine Expression Targets
|
|
PAF/Gq -> NF-kB Expression Targets
|
|
PGE1 Expression Targets
|
|
Proteins/Ions Transporters -> Expression Targets in Lymphoid System and Blood
|
|
Elevated Receptors -> Expression Targets in Lymphoid System and Blood
|
|
NOTCH -> Expression Targets in Thymus
|
|
Elevated Receptors -> Expression Targets in Thymus
|
|
NGF -> SMAD3/NF-kB Expression Targets
|
|
NGF -> AP-1/TP53/MYC Expression Targets
|
|
NGF -> CREB/CEBPB/MEF2A Expression Targets
|
|
JAG1 Expression Targets
|
|
NOTCH Expression Targets
|
|
Adenosine Expression Targets
|
|
GNRH1 Expression Targets
|
|
CCL11 Expression Targets
|
|
NPY Expression Targets
|
|
Collagen -> NF-kB Expression Targets
|
|
PAF Expression Targets
|
|
TCR -> NF-kB Expression Targets
|
|
TCR -> NFAT Expression Targets
|
|
TCR -> AP-1 Expression Targets
|
|
TGFB1-TGFBR1 Expression Targets
|
|
TNFSF14 Expression Targets
|
|
CD72 -> AP-1 Expression Targets
|
|
CD40LG -> NF-kB/ELK/SRF -> CREB/NFATC Expression Targets
|
|
TNFSF13B Expression Targets
|
|
TLR4 -> AP-1 Expression Targets
|
|
TLR4 -> NF-kB/IRF Expression Targets
|
|
B-Cell Differentiation Inhibition by Dioxin
|
|
PPAR Psoriasis
|
|
Model of PPARG signaling in psoriasis
|
|
IFN signaling in alveolar cells
|
|
Overview. Diseases of the skin (chapter 11)
|
|
Overview. Diseases of the respiratory (chapter 9)
|
|
2_Acute phase initiation in atopic dermatitis
|
|
1_Differentiation of psoriatic T cells
|
|
1_The onset of atopic dermatitis
|
|
1_Th2 cell response in asthma
|
|
3_2_Regulation of airway surface liquid (ASL) thickness
|
|
3_1_Mucus accumulation in asthma
|
|
2_2_Eosinophilia and neutrophilia in asthma: eosinophil apoptosis
|
|
4_Mucin hyperproduction in goblet and mucous cells in COPD
|
|
3_Leukocyte migration toward the endothelial cells in the intestine microvasculature
|
|
2_Intestine epithelial cells drive immunological responses in ulcerative colitis
|
|
4_1_Polymorphisms associated with inflammatory bowel diseases
|
|
1_CD4+ T cell and epithelial cell response in celiac disease
|
|
2_Defective tolerance of autoreactive T-cell in T1D
|
|
drug-target moltransport
|
|
Differentiation of psoriatic T cells
|